ArticleHepatology (Baltimore, Md.)2019

Mammalian Target of Rapamycin Inhibitors, New Drugs for Beta-Catenin-Mutated Hepatocellular Carcinomas?

Christine Perret et al.PubMed ↗Publisher ↗

No numbers read from the abstract.